 | Articles: Drug Trials |
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis
Corporate News Releases, 06/16/08
The Power of Hypothesis
BioPharm, 06/13/08
Roche moves investigational diabetes drug, taspoglutide, into phase iii clinical trials
Roche, 06/13/08
Ofatumumab in subcutaneous study in rheumatoid arthritis
Genmab, 06/13/08
Biovest Reports Blinded Results for Phase 3 Study Evaluating Anti-Cancer Vaccine, BiovaxID(R), which Shows 100% Difference in Disease-Free Survival at 36 Months in the Comparative Arms
Corporate News Releases, 06/13/08
Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
Corporate News Releases, 06/13/08
Phase 3 Data Show Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-TNF Agents
Corporate News Releases, 06/13/08
Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
Corporate News Releases, 06/12/08
Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
Amylin Pharmaceuticals, 06/12/08
Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
Amylin Pharmaceuticals, 06/12/08
|
 Receive daily email updates on Drug Trials
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
